Xinhua News Agency, Brussels, September 9 (Reporter Ren Ke) The European Medicines Agency said on the 9th that there is evidence that immunosuppressed patients and some elderly patients need to be vaccinated with additional doses of the new crown vaccine
Marco Cavalieri, head of the vaccine department of the European Medicines Agency, said at a press conference that day that there is increasingly clear evidence that people who do not respond well to the vaccine need to be vaccinated with additional doses of the new crown vaccine, such as those with weakened immunity and some Elderly patients
Cavalieri said that the current evidence shows that the new crown vaccine has a high protective effect on preventing hospitalization, severe illness and death
He said that the European Medicines Agency is evaluating the recommendations made by the new crown vaccine manufacturer German Biotech and Pfizer Pharmaceuticals in the United States that people over the age of 16 should receive a booster shot for at least 6 months after receiving the second dose of the vaccine.
According to data from the European Medicines Agency, as of the beginning of September, the EU and the European Economic Area had received more than 528 million doses of the new crown vaccine.
7.
5 Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
